These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30078623)

  • 1. Diabetes-related cardiomyopathy: The sweet story of glucose overload from epidemiology to cellular pathways.
    Joubert M; Manrique A; Cariou B; Prieur X
    Diabetes Metab; 2019 Jun; 45(3):238-247. PubMed ID: 30078623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of hyperglycaemia in the development of diabetic cardiomyopathy.
    El Hayek MS; Ernande L; Benitah JP; Gomez AM; Pereira L
    Arch Cardiovasc Dis; 2021 Nov; 114(11):748-760. PubMed ID: 34627704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart Failure in Type 2 Diabetes Mellitus.
    Kenny HC; Abel ED
    Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy.
    Alonso N; Moliner P; Mauricio D
    Adv Exp Med Biol; 2018; 1067():197-217. PubMed ID: 28980272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Role of Glucose Overload in Diabetic Cardiomyopathy in Nonhuman Primates.
    Wang X; Jin S; Hu W
    J Diabetes Res; 2021; 2021():9676754. PubMed ID: 33860059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of Glucose.
    Ducheix S; Magré J; Cariou B; Prieur X
    Front Endocrinol (Lausanne); 2018; 9():642. PubMed ID: 30420836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial glucotoxicity: Mechanisms and potential therapeutic targets.
    Battault S; Renguet E; Van Steenbergen A; Horman S; Beauloye C; Bertrand L
    Arch Cardiovasc Dis; 2020 Nov; 113(11):736-748. PubMed ID: 33189592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [At the heart of diabetic cardiomyopathy: Bscl2 knockout mice to investigate glucotoxicity].
    Lugat A; Joubert M; Cariou B; Prieur X
    Med Sci (Paris); 2018; 34(6-7):563-570. PubMed ID: 30067203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 and SGLT2 Inhibitors-A Therapeutic Perspective for Diabetic Cardiomyopathy.
    Saha S; Fang X; Green CD; Das A
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of SIRT1 in diabetic cardiomyopathy.
    Karbasforooshan H; Karimi G
    Biomed Pharmacother; 2017 Jun; 90():386-392. PubMed ID: 28380414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms.
    Mahmoud AM
    Adv Exp Med Biol; 2017; 999():207-230. PubMed ID: 29022265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
    Khan S; Ahmad SS; Kamal MA
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance.
    Kalfon R; Koren L; Aviram S; Schwartz O; Hai T; Aronheim A
    Cardiovasc Res; 2017 Feb; 113(2):134-146. PubMed ID: 28082453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the
    Sun Y; Wang Q; Fang Y; Wu C; Lu G; Chen Z
    Dis Model Mech; 2017 Oct; 10(10):1217-1227. PubMed ID: 28801532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential.
    Faria A; Persaud SJ
    Pharmacol Ther; 2017 Apr; 172():50-62. PubMed ID: 27916650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding of structural and molecular changes in diabetic cardiomyopathy.
    Akhtar MS; Alavudeen SS; Raza A; Imam MT; Almalki ZS; Tabassum F; Iqbal MJ
    Life Sci; 2023 Nov; 332():122087. PubMed ID: 37714373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus.
    Graczyk P; Dach A; Dyrka K; Pawlik A
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy.
    Zhao MX; Zhou B; Ling L; Xiong XQ; Zhang F; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Death Dis; 2017 Mar; 8(3):e2690. PubMed ID: 28333148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
    Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.